These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6182409)

  • 21. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
    Carvalho CA; Coutinho OP; Carvalho AP
    J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of bepridil into isolated ventricular myocytes. Retention by actin.
    Cramb G; Dow JW
    Biochem Pharmacol; 1983 Jan; 32(2):227-31. PubMed ID: 6603218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bepridil on Ca2+ uptake by cardiac mitochondria.
    Younes A; Schneider JM
    Biochem Pharmacol; 1984 Apr; 33(8):1363-6. PubMed ID: 6231932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of sodium-calcium exchange and effects of calcium entry blockers on endothelial-mediated responses in rat isolated aorta.
    Schoeffter P; Miller RC
    Mol Pharmacol; 1986 Jul; 30(1):53-7. PubMed ID: 3014308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of Ca2+ channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes.
    Chen M; Xiao CY; Hashizume H; Abiko Y
    Eur J Pharmacol; 1997 Aug; 333(2-3):261-8. PubMed ID: 9314043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the calcium antagonists bepridil (CERM-1978) and verapamil on Ca++-dependent slow action potentials in frog skeletal muscle.
    Kerr LM; Sperelakis N
    J Pharmacol Exp Ther; 1982 Jul; 222(1):80-6. PubMed ID: 6979625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ion channel inhibitors on the cytopathogenicity of Entamoeba histolytica.
    Ravdin JI; Sperelakis N; Guerrant RL
    J Infect Dis; 1982 Sep; 146(3):335-40. PubMed ID: 6286794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bepridil, myocardial accumulation kinetics and dynamic effects in the isolated rabbit heart.
    Nielsen-Kudsk F; Askholt J; Jakobsen P
    Pharmacol Toxicol; 1988 Aug; 63(2):122-8. PubMed ID: 3263633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diphenylalkylamine calcium antagonists interact with alpha-adrenoceptor binding sites in aortic membranes.
    Descombes JJ; Stoclet JC
    Eur J Pharmacol; 1985 Sep; 115(2-3):313-6. PubMed ID: 2998828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H] verapamil binding sites in skeletal muscle transverse tubule membranes.
    Galizzi JP; Fosset M; Lazdunski M
    Biochem Biophys Res Commun; 1984 Jan; 118(1):239-45. PubMed ID: 6696758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and metabolism of bepridil.
    Benet LZ
    Am J Cardiol; 1985 Mar; 55(7):8C-13C. PubMed ID: 3872057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
    Zhang WM; Wang HX; Xia Q; Wong TM
    Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of omega-conotoxin GVIA on noradrenaline release from postganglionic sympathetic neurones in rabbit aorta.
    Nedergaard OA
    Pharmacol Toxicol; 2000 Jan; 86(1):30-5. PubMed ID: 10720104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 2. Mechanism of inhibition by bepridil.
    Garcia ML; Slaughter RS; King VF; Kaczorowski GJ
    Biochemistry; 1988 Apr; 27(7):2410-5. PubMed ID: 3260109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the mechanism of negative inotropic activity of some calcium antagonists.
    Boddeke HW; Wilffert B; Heynis JB; van Zwieten PA
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):321-5. PubMed ID: 2452925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of verapamil and bepridil, two slow channel inhibitors, in protection against calcium-induced arrhythmias.
    Chollet-Debord F; Moins N; Gachon P; Duchene-Marullaz P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Sep; 334(1):105-9. PubMed ID: 3491328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-dependent effects of bepridil on Ca2+-extrusion across rat heart sarcolemma.
    Van Amsterdam FT; Zaagsma J
    Arch Int Pharmacodyn Ther; 1989; 298():90-5. PubMed ID: 2787975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression of automaticity of the rabbit SA node by bepridil and nifedipine.
    Goto J; Sperelakis N
    Eur J Pharmacol; 1984 Mar; 99(2-3):227-31. PubMed ID: 6610560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.